Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Inhibition of HIV Replication by Apolipoprotein A-I Binding Protein Targeting the Lipid Rafts.

Dubrovsky L, Ward A, Choi SH, Pushkarsky T, Brichacek B, Vanpouille C, Adzhubei AA, Mukhamedova N, Sviridov D, Margolis L, Jones RB, Miller YI, Bukrinsky M.

mBio. 2020 Jan 21;11(1). pii: e02956-19. doi: 10.1128/mBio.02956-19.

2.

Extracellular vesicles from symbiotic vaginal lactobacilli inhibit HIV-1 infection of human tissues.

Ñahui Palomino RA, Vanpouille C, Laghi L, Parolin C, Melikov K, Backlund P, Vitali B, Margolis L.

Nat Commun. 2019 Dec 11;10(1):5656. doi: 10.1038/s41467-019-13468-9.

3.

Cytokine Network and Sexual HIV Transmission in Men Who Have Sex With Men.

Vanpouille C, Frick A, Rawlings SA, Hoenigl M, Lisco A, Margolis L, Gianella S.

Clin Infect Dis. 2019 Nov 26. pii: ciz1150. doi: 10.1093/cid/ciz1150. [Epub ahead of print]

PMID:
31768525
4.

Corrigendum: Paradoxical CD4 Lymphopenia in Autoimmune Lymphoproliferative Syndrome (ALPS).

Lisco A, Wong CS, Price S, Ye P, Niemela J, Anderson M, Richards E, Manion M, Mystakelis H, Similuk M, Lo B, Stoddard J, Rosenzweig S, Vanpouille C, Rupert A, Maric I, Perez-Diez A, Parenti D, Burbelo PD, Rao VK, Sereti I.

Front Immunol. 2019 Jul 4;10:1552. doi: 10.3389/fimmu.2019.01552. eCollection 2019.

5.

Paradoxical CD4 Lymphopenia in Autoimmune Lymphoproliferative Syndrome (ALPS).

Lisco A, Wong CS, Price S, Ye P, Niemela J, Anderson M, Richards E, Manion M, Mystakelis H, Similuk M, Lo B, Stoddard J, Rosenzweig S, Vanpouille C, Rupert A, Maric I, Perez-Diez A, Parenti D, Burbelo PD, Rao VK, Sereti I.

Front Immunol. 2019 May 29;10:1193. doi: 10.3389/fimmu.2019.01193. eCollection 2019. Erratum in: Front Immunol. 2019 Jul 04;10:1552.

6.

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture.

Introini A, Vanpouille C, Fitzgerald W, Broliden K, Margolis L.

J Vis Exp. 2018 Oct 12;(140). doi: 10.3791/57013.

7.

Human cytomegalovirus-infected cells release extracellular vesicles that carry viral surface proteins.

Zicari S, Arakelyan A, Palomino RAÑ, Fitzgerald W, Vanpouille C, Lebedeva A, Schmitt A, Bomsel M, Britt W, Margolis L.

Virology. 2018 Nov;524:97-105. doi: 10.1016/j.virol.2018.08.008. Epub 2018 Aug 27.

8.

Histoculture and Infection with HIV of Functional Human Lymphoid Tissue on Gelfoam®.

Introini A, Fitzgerald W, Vanpouille C, Margolis L.

Methods Mol Biol. 2018;1760:187-197. doi: 10.1007/978-1-4939-7745-1_17.

9.

Cytomegalovirus and HIV Persistence: Pouring Gas on the Fire.

Christensen-Quick A, Vanpouille C, Lisco A, Gianella S.

AIDS Res Hum Retroviruses. 2017 Nov;33(S1):S23-S30. doi: 10.1089/aid.2017.0145. Review.

10.

Virtual Screening of Acyclovir Derivatives as Potential Antiviral Agents: Design, Synthesis, and Biological Evaluation of New Acyclic Nucleoside ProTides.

Derudas M, Vanpouille C, Carta D, Zicari S, Andrei G, Snoeck R, Brancale A, Margolis L, Balzarini J, McGuigan C.

J Med Chem. 2017 Sep 28;60(18):7876-7896. doi: 10.1021/acs.jmedchem.7b01009. Epub 2017 Sep 19.

11.

Dual-targeted anti-TB/anti-HIV heterodimers.

Alexandrova L, Zicari S, Matyugina E, Khandazhinskaya A, Smirnova T, Andreevskaya S, Chernousova L, Vanpouille C, Kochetkov S, Margolis L.

Antiviral Res. 2017 Sep;145:175-183. doi: 10.1016/j.antiviral.2017.07.011. Epub 2017 Jul 22.

12.

A common anti-cytomegalovirus drug, ganciclovir, inhibits HIV-1 replication in human tissues ex vivo.

Vanpouille C, Bernatchez JA, Lisco A, Arakelyan A, Saba E, Götte M, Margolis L.

AIDS. 2017 Jul 17;31(11):1519-1528. doi: 10.1097/QAD.0000000000001532.

13.

Vaginal Lactobacillus Inhibits HIV-1 Replication in Human Tissues Ex Vivo.

Ñahui Palomino RA, Zicari S, Vanpouille C, Vitali B, Margolis L.

Front Microbiol. 2017 May 19;8:906. doi: 10.3389/fmicb.2017.00906. eCollection 2017.

14.

Extracellular Vesicles Carry HIV Env and Facilitate Hiv Infection of Human Lymphoid Tissue.

Arakelyan A, Fitzgerald W, Zicari S, Vanpouille C, Margolis L.

Sci Rep. 2017 May 10;7(1):1695. doi: 10.1038/s41598-017-01739-8.

15.

Monocytes but Not Lymphocytes Carrying HIV-1 on Their Surface Transmit Infection to Human Tissue Ex Vivo.

Barreto-de-Souza V, Arakelyan A, Zicari S, Margolis L, Vanpouille C.

J Virol. 2016 Oct 14;90(21):9833-9840. doi: 10.1128/JVI.00742-16. Print 2016 Nov 1.

16.

HIV Trafficking Between Blood and Semen During Early Untreated HIV Infection.

Chaillon A, Smith DM, Vanpouille C, Lisco A, Jordan P, Caballero G, Vargas M, Gianella S, Mehta SR.

J Acquir Immune Defic Syndr. 2017 Jan 1;74(1):95-102.

17.

Standardization of a cytometric p24-capture bead-assay for the detection of main HIV-1 subtypes.

Merbah M, Onkar S, Grivel JC, Vanpouille C, Biancotto A, Bonar L, Sanders-Buell E, Kijak G, Michael N, Robb M, Kim JH, Tovanabutra S, Chenine AL.

J Virol Methods. 2016 Apr;230:45-52. doi: 10.1016/j.jviromet.2016.01.009. Epub 2016 Jan 22.

18.

Distinct cytokine/chemokine network in semen and blood characterize different stages of HIV infection.

Vanpouille C, Introini A, Morris SR, Margolis L, Daar ES, Dube MP, Little SJ, Smith DM, Lisco A, Gianella S.

AIDS. 2016 Jan;30(2):193-201. doi: 10.1097/QAD.0000000000000964.

19.

5-Arylaminouracil Derivatives as Potential Dual-Action Agents.

Matyugina ES, Novikov MS, Babkov DA, Valuev-Elliston VT, Vanpouille C, Zicari S, Corona A, Tramontano E, Margolis LB, Khandazhinskaya AL, Kochetkov SN.

Acta Naturae. 2015 Jul-Sep;7(3):113-5.

20.

Genital Cytomegalovirus Replication Predicts Syphilis Acquisition among HIV-1 Infected Men Who Have Sex with Men.

Gianella S, Smith DM, Daar ES, Dube MP, Lisco A, Vanpouille C, Margolis L, Haubrich RH, Morris SR.

PLoS One. 2015 Jun 10;10(6):e0130410. doi: 10.1371/journal.pone.0130410. eCollection 2015.

21.

Valacyclovir Decreases Plasma HIV-1 RNA in HSV-2 Seronegative Individuals: A Randomized Placebo-Controlled Crossover Trial.

Vanpouille C, Lisco A, Grivel JC, Bassit LC, Kauffman RC, Sanchez J, Schinazi RF, Lederman MM, Rodriguez B, Margolis L.

Clin Infect Dis. 2015 Jun 1;60(11):1708-14. doi: 10.1093/cid/civ172. Epub 2015 Mar 3.

22.

A new antiviral: chimeric 3TC-AZT phosphonate efficiently inhibits HIV-1 in human tissues ex vivo.

Vanpouille C, Khandazhinskaya A, Karpenko I, Zicari S, Barreto-de-Souza V, Frolova S, Margolis L, Kochetkov S.

Antiviral Res. 2014 Sep;109:125-31. doi: 10.1016/j.antiviral.2014.06.019. Epub 2014 Jul 7.

23.

HIV-1 vaginal transmission: cell-free or cell-associated virus?

Barreto-de-Souza V, Arakelyan A, Margolis L, Vanpouille C.

Am J Reprod Immunol. 2014 Jun;71(6):589-99. doi: 10.1111/aji.12240. Epub 2014 Apr 15. Review.

24.

An ex vivo Model of HIV-1 Infection in Human Lymphoid Tissue and Cervico-vaginal Tissue.

Introini A, Vanpouille C, Grivel JC, Margolis L.

Bio Protoc. 2014;4(4). pii: e1047.

25.

Design, synthesis and biological evaluation of phosphorodiamidate prodrugs of antiviral and anticancer nucleosides.

McGuigan C, Bourdin C, Derudas M, Hamon N, Hinsinger K, Kandil S, Madela K, Meneghesso S, Pertusati F, Serpi M, Slusarczyk M, Chamberlain S, Kolykhalov A, Vernachio J, Vanpouille C, Introini A, Margolis L, Balzarini J.

Eur J Med Chem. 2013;70:326-40. doi: 10.1016/j.ejmech.2013.09.047. Epub 2013 Oct 9.

26.

Histocultures (tissue explants) in human retrovirology.

Arakelyan A, Fitzgerald W, Grivel JC, Vanpouille C, Margolis L.

Methods Mol Biol. 2014;1087:233-48. doi: 10.1007/978-1-62703-670-2_19.

27.

A multi-targeted drug candidate with dual anti-HIV and anti-HSV activity.

Balzarini J, Andrei G, Balestra E, Huskens D, Vanpouille C, Introini A, Zicari S, Liekens S, Snoeck R, Holý A, Perno CF, Margolis L, Schols D.

PLoS Pathog. 2013;9(7):e1003456. doi: 10.1371/journal.ppat.1003456. Epub 2013 Jul 25.

28.

Interleukin-7 facilitates HIV-1 transmission to cervico-vaginal tissue ex vivo.

Introini A, Vanpouille C, Lisco A, Grivel JC, Margolis L.

PLoS Pathog. 2013 Feb;9(2):e1003148. doi: 10.1371/journal.ppat.1003148. Epub 2013 Feb 7.

29.

HIV-1 imposes rigidity on blood and semen cytokine networks.

Lisco A, Introini A, Munawwar A, Vanpouille C, Grivel JC, Blank P, Singh S, Margolis L.

Am J Reprod Immunol. 2012 Dec;68(6):515-21. doi: 10.1111/aji.12015. Epub 2012 Sep 24.

30.

Microbicides: still a long road to success.

Vanpouille C, Arakelyan A, Margolis L.

Trends Microbiol. 2012 Aug;20(8):369-75. doi: 10.1016/j.tim.2012.05.005. Epub 2012 Jun 15. Review.

31.

Exploiting the anti-HIV-1 activity of acyclovir: suppression of primary and drug-resistant HIV isolates and potentiation of the activity by ribavirin.

Vanpouille C, Lisco A, Introini A, Grivel JC, Munawwar A, Merbah M, Schinazi RF, Derudas M, McGuigan C, Balzarini J, Margolis L.

Antimicrob Agents Chemother. 2012 May;56(5):2604-11. doi: 10.1128/AAC.05986-11. Epub 2012 Feb 6.

32.

Semen of HIV-1-infected individuals: local shedding of herpesviruses and reprogrammed cytokine network.

Lisco A, Munawwar A, Introini A, Vanpouille C, Saba E, Feng X, Grivel JC, Singh S, Margolis L.

J Infect Dis. 2012 Jan 1;205(1):97-105. doi: 10.1093/infdis/jir700. Epub 2011 Nov 22.

33.

Topical tenofovir, a microbicide effective against HIV, inhibits herpes simplex virus-2 replication.

Andrei G, Lisco A, Vanpouille C, Introini A, Balestra E, van den Oord J, Cihlar T, Perno CF, Snoeck R, Margolis L, Balzarini J.

Cell Host Microbe. 2011 Oct 20;10(4):379-89. doi: 10.1016/j.chom.2011.08.015.

34.

Cervico-vaginal tissue ex vivo as a model to study early events in HIV-1 infection.

Merbah M, Introini A, Fitzgerald W, Grivel JC, Lisco A, Vanpouille C, Margolis L.

Am J Reprod Immunol. 2011 Mar;65(3):268-78. doi: 10.1111/j.1600-0897.2010.00967.x. Epub 2011 Jan 12.

35.

Contrasting roles for TLR ligands in HIV-1 pathogenesis.

Brichacek B, Vanpouille C, Kiselyeva Y, Biancotto A, Merbah M, Hirsch I, Lisco A, Grivel JC, Margolis L.

PLoS One. 2010 Sep 20;5(9). pii: e12831. doi: 10.1371/journal.pone.0012831.

36.

HIV-1 sexual transmission: early events of HIV-1 infection of human cervico-vaginal tissue in an optimized ex vivo model.

Saba E, Grivel JC, Vanpouille C, Brichacek B, Fitzgerald W, Margolis L, Lisco A.

Mucosal Immunol. 2010 May;3(3):280-90. doi: 10.1038/mi.2010.2. Epub 2010 Feb 10.

37.

A new class of dual-targeted antivirals: monophosphorylated acyclovir prodrug derivatives suppress both human immunodeficiency virus type 1 and herpes simplex virus type 2.

Vanpouille C, Lisco A, Derudas M, Saba E, Grivel JC, Brichacek B, Scrimieri F, Schinazi R, Schols D, McGuigan C, Balzarini J, Margolis L.

J Infect Dis. 2010 Feb 15;201(4):635-43. doi: 10.1086/650343.

38.

War and peace between microbes: HIV-1 interactions with coinfecting viruses.

Lisco A, Vanpouille C, Margolis L.

Cell Host Microbe. 2009 Nov 19;6(5):403-8. doi: 10.1016/j.chom.2009.10.010. Review.

39.

Acyclovir: a new use for an old drug.

Vanpouille C, Lisco A, Margolis L.

Curr Opin Infect Dis. 2009 Dec;22(6):583-7. doi: 10.1097/QCO.0b013e32833229b8. Review.

PMID:
19726982
40.

A missed point in deciphering the viral synergy between herpes simplex virus and HIV.

Lisco A, Vanpouille C, Margolis L.

Lancet Infect Dis. 2009 Sep;9(9):522-3. doi: 10.1016/S1473-3099(09)70209-9. No abstract available.

41.

The application of phosphoramidate protide technology to acyclovir confers anti-HIV inhibition.

Derudas M, Carta D, Brancale A, Vanpouille C, Lisco A, Margolis L, Balzarini J, McGuigan C.

J Med Chem. 2009 Sep 10;52(17):5520-30. doi: 10.1021/jm9007856.

42.

Evolution of SIV toward RANTES resistance in macaques rapidly progressing to AIDS upon coinfection with HHV-6A.

Biancotto A, Grivel JC, Lisco A, Vanpouille C, Markham PD, Gallo RC, Margolis LB, Lusso P.

Retrovirology. 2009 Jul 2;6:61. doi: 10.1186/1742-4690-6-61.

43.

Mechanisms associated with HIV-1 resistance to acyclovir by the V75I mutation in reverse transcriptase.

Tchesnokov EP, Obikhod A, Massud I, Lisco A, Vanpouille C, Brichacek B, Balzarini J, McGuigan C, Derudas M, Margolis L, Schinazi RF, Götte M.

J Biol Chem. 2009 Aug 7;284(32):21496-504. doi: 10.1074/jbc.M109.024026. Epub 2009 Jun 9.

44.

Influence of multidrug resistance on (18)F-FCH cellular uptake in a glioblastoma model.

Vanpouille C, Le Jeune N, Kryza D, Clotagatide A, Janier M, Dubois F, Perek N.

Eur J Nucl Med Mol Imaging. 2009 Aug;36(8):1256-64. doi: 10.1007/s00259-009-1101-5. Epub 2009 Mar 20.

PMID:
19300998
45.

Coinfecting viruses as determinants of HIV disease.

Lisco A, Vanpouille C, Margolis L.

Curr HIV/AIDS Rep. 2009 Feb;6(1):5-12. Review.

46.

A highly sensitive and dynamic immunofluorescent cytometric bead assay for the detection of HIV-1 p24.

Biancotto A, Brichacek B, Chen SS, Fitzgerald W, Lisco A, Vanpouille C, Margolis L, Grivel JC.

J Virol Methods. 2009 Apr;157(1):98-101. doi: 10.1016/j.jviromet.2008.11.013. Epub 2009 Jan 6.

47.

Acyclovir is activated into a HIV-1 reverse transcriptase inhibitor in herpesvirus-infected human tissues.

Lisco A, Vanpouille C, Tchesnokov EP, Grivel JC, Biancotto A, Brichacek B, Elliott J, Fromentin E, Shattock R, Anton P, Gorelick R, Balzarini J, McGuigan C, Derudas M, Götte M, Schinazi RF, Margolis L.

Cell Host Microbe. 2008 Sep 11;4(3):260-270. doi: 10.1016/j.chom.2008.07.008.

48.

HSV-2 suppression and the incidence of HIV.

Lisco A, Vanpouille C.

N Engl J Med. 2008 Jul 31;359(5):535; author reply 535. doi: 10.1056/NEJMc081075. No abstract available.

PMID:
18669436
49.

Upregulation of human cytomegalovirus by HIV type 1 in human lymphoid tissue ex vivo.

Biancotto A, Iglehart SJ, Lisco A, Vanpouille C, Grivel JC, Lurain NS, Reichelderfer PS, Margolis LB.

AIDS Res Hum Retroviruses. 2008 Mar;24(3):453-62. doi: 10.1089/aid.2007.0155.

PMID:
18327985
50.

HIV-1 induced activation of CD4+ T cells creates new targets for HIV-1 infection in human lymphoid tissue ex vivo.

Biancotto A, Iglehart SJ, Vanpouille C, Condack CE, Lisco A, Ruecker E, Hirsch I, Margolis LB, Grivel JC.

Blood. 2008 Jan 15;111(2):699-704. Epub 2007 Oct 1.

Supplemental Content

Loading ...
Support Center